| scholarly article | Q13442814 |
| P50 | author | Benedetta C Sallustio | Q88974744 |
| P2093 | author name string | Andrew A Somogyi | |
| Jonathan Tuke | |||
| Robert P Carroll | |||
| Brett C McWhinney | |||
| Janet K Coller | |||
| Zaipul I Md Dom | |||
| P2860 | cites work | Mycophenolic acid quantification in human peripheral blood mononuclear cells using liquid chromatography-tandem mass spectrometry | Q85987982 |
| A New Statistical Method for Haplotype Reconstruction from Population Data | Q27860495 | ||
| Characterization of human type I and type II IMP dehydrogenases | Q28623113 | ||
| Multidrug resistance protein (MRP) activity in normal mature leukocytes and CD34-positive hematopoietic cells from peripheral blood | Q32101964 | ||
| Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion | Q34321841 | ||
| Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant | Q35826828 | ||
| Therapeutic drug monitoring of mycophenolate mofetil in transplantation | Q36455259 | ||
| Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients. | Q37161962 | ||
| Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation | Q37670499 | ||
| Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function. | Q39721177 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients | Q40501892 | ||
| P-glycoprotein expression and function in circulating blood cells from normal volunteers. | Q41472406 | ||
| Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics | Q41674253 | ||
| THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters | Q42660436 | ||
| THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes | Q42660454 | ||
| The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy. | Q42670520 | ||
| Inosine monophosphate dehydrogenase messenger RNA expression is correlated to clinical outcomes in mycophenolate mofetil-treated kidney transplant patients, whereas inosine monophosphate dehydrogenase activity is not. | Q43286711 | ||
| Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients | Q43463833 | ||
| Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation. | Q43654390 | ||
| Monitoring of inosine monophosphate dehydrogenase activity and expression during the early period of mycophenolate mofetil therapy in de novo renal transplant patients | Q44065833 | ||
| Cyclosporine lymphocyte versus whole blood pharmacokinetic monitoring: correlation with histological findings | Q44511304 | ||
| Pre-transplant inosine monophosphate dehydrogenase activity is associated with clinical outcome after renal transplantation | Q45171034 | ||
| Validation of an LC-MS/MS method for the quantification of mycophenolic acid in human kidney transplant biopsies. | Q45905123 | ||
| Improved assay for the nonradioactive determination of inosine 5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells. | Q46068408 | ||
| Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells | Q46213509 | ||
| Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasma | Q46313857 | ||
| Renal glucuronidation and multidrug resistance protein 2-/ multidrug resistance protein 4-mediated efflux of mycophenolic acid: interaction with cyclosporine and tacrolimus. | Q46498636 | ||
| Maximum a posteriori bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods | Q46500161 | ||
| The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY. | Q47139831 | ||
| Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid. | Q50972464 | ||
| Plasma and intracellular pharmacokinetic-pharmacodynamic analysis of mycophenolic acid in de novo kidney transplant patients. | Q52981428 | ||
| Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expression | Q72666691 | ||
| Membrane transport of mycophenolate mofetil and its active metabolite, mycophenolic acid in MDCK and MDR1-MDCK cell monolayers | Q73618682 | ||
| Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients | Q79294815 | ||
| Determination of ciclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography-tandem mass spectrometry | Q79775530 | ||
| Cyclosporine lymphocyte maximum level monitoring in de novo kidney transplant patients: a prospective study | Q79858287 | ||
| Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients | Q80532644 | ||
| Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study | Q85061519 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 2433-2442 | |
| P577 | publication date | 2018-08-07 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Mycophenolic acid concentrations in peripheral blood mononuclear cells are associated with the incidence of rejection in renal transplant recipients | |
| P478 | volume | 84 |
Search more.